CME Group Inc. (NASDAQ:CME) Stock Holdings Increased by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 9.5% during the 2nd quarter, Holdings Channel reports. The fund owned 18,570 shares of the financial services provider’s stock after purchasing an additional 1,612 shares during the period. GHP Investment Advisors Inc.’s holdings in CME Group were worth $3,651,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in the business. Aveo Capital Partners LLC acquired a new position in shares of CME Group during the 4th quarter valued at $226,000. 9258 Wealth Management LLC grew its holdings in shares of CME Group by 3.7% in the 4th quarter. 9258 Wealth Management LLC now owns 3,148 shares of the financial services provider’s stock worth $663,000 after acquiring an additional 113 shares during the last quarter. Gryphon Financial Partners LLC acquired a new position in shares of CME Group in the 4th quarter worth $547,000. Avantax Advisory Services Inc. grew its holdings in shares of CME Group by 2.0% in the 4th quarter. Avantax Advisory Services Inc. now owns 7,097 shares of the financial services provider’s stock worth $1,495,000 after acquiring an additional 141 shares during the last quarter. Finally, Quadrant Capital Group LLC grew its holdings in shares of CME Group by 9.7% in the 4th quarter. Quadrant Capital Group LLC now owns 3,711 shares of the financial services provider’s stock worth $782,000 after acquiring an additional 328 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft lifted their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Piper Sandler restated an “overweight” rating and issued a $225.00 target price on shares of CME Group in a report on Tuesday, August 20th. Keefe, Bruyette & Woods raised their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. raised their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Finally, Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Four research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $209.73.

CME Group Price Performance

CME opened at $216.99 on Friday. The stock has a market cap of $78.13 billion, a price-to-earnings ratio of 24.69, a PEG ratio of 8.85 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a fifty day moving average price of $205.69 and a 200 day moving average price of $207.67.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same quarter last year, the firm earned $2.30 earnings per share. Analysts forecast that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be given a $1.15 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.12%. CME Group’s dividend payout ratio is currently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.